Dr. Alan Copperman

Dr. Alan Copperman is Director of the Division of Reproductive Endocrinology and Infertility, and the Vice Chairman of the Department of Obstetrics, Gynecology and Reproductive Science, at Mount Sinai Medical Center.  He’s also a prolific author who has coauthored over 300 scientific abstracts on topics including infertility, in vitro fertilization (IVF), egg freezing, ovum donation, and genetics, and who has published more than 100 original manuscripts and book chapters on reproductive medicine.

Dr. Alan Copperman is the Director of the Division of Reproductive Endocrinology and Infertility as well as the Vice-Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai Medical Center. He’s a leading physician in the field of reproductive medicine, and he’s passionate about helping his patients achieve the dream of building a family using the latest in modern medicine. Since beginning his career, he has written over 100 original manuscripts and book chapters on reproductive medicine, and has co-authored over 300 scientific abstracts on infertility, in vitro fertilization, egg freezing, ovum donation, and reproductive genetics. Recently, Dr. Alan Copperman was quoted in an article titled “ Precision Medicine Moves from Promise to Reality ,” which was featured on Scientific American.  “We help develop decision-support tools so patients understand what this information means in the context of themselves, their families, and their...

Since 2017, Dr. Alan Copperman has served as Medical Director at Progyny, Inc. – an innovative fertility benefits company that provides both physicians and members the coverage they need to focus on successful outcomes and effective treatment. Through smart fertility benefits supported by innovative fertility science, Proygyny is working to make the dream of parenthood come true for members across the country. Dr. Alan Copperman and the Proygyny team partner with leading employers across the nation to help employees achieve a higher rate of pregnancy success – to provide members access to a comprehensive fertility approach that includes:  A top fertility specialist network of more than 500 locations throughout the United States.   Care advocates that offer guidance to patients on the path to parenthood.   An emotional wellness tool that helps ease the journey to fertility.   An all-inclusive benefit that doesn’t require pre-certification.

Dr. Alan Copperman has been a leading member of the reproductive medicine community for more than 25 years. Presently, Dr. Copperman enjoys leadership roles with several notable organizations, including serving as Director of Reproductive Endocrinology and Infertility at the Mount Sinai Medical Center (since 1993); Medical Director at Reproductive Medicine Associates of New York (since 2001); Medical Director at Progyny, Inc. (since August 2017); and Chief Medical Officer at Sema4 (since August 2017).

Dr. Alan B. Copperman is a fertility specialist who leads Reproductive Medicine Associates of New York and serves as Director of the Division of Reproductive Endocrinology and Infertility at The Icahn School of Medicine at Mount Sina. He’s a prolific medical author and an award-winning professional, and he’s been named to New York Magazine’s list of Best Doctors for seventeen years in a row. Since beginning his career, Dr. Alan B. Copperman has helped bring thousands of family-building dreams to life, and he’s received praise from patients everywhere. A couple of the many are highlighted below: ·          “My wife just gave birth to a wonderful baby boy - a boy who wouldn’t exist if it weren’t for Doctor Copperman,” wrote one patient. ·          “Dr. Copperman is one of the most caring, knowledgeable doctors I have ever seen. I have been to him twice, for two different issues, and each time ...

Dr. Alan B. Copperman is an award-winning professional who serves as the Medical Director of Reproductive Medicine Associates of New York. He’s also a medical author whose 2018 piece titled “ How Supplemental Newborn Screening Could Improve Patient Care ” in MD Magazine stirred up discussion.  “A deeper understanding of the association between genetic variants and disease has made it possible to develop supplemental newborn screening tests that focus on childhood-onset disorders and diseases for which a medical intervention is available. Such genetic tests can also provide information about a child’s likely response to medications commonly prescribed at a young age,”   wrote Dr. Alan B.Copperman before discussing the validity of common concerns about genetic testing. To check out the work that Dr. Alan B. Copperman’s team does at Reproductive Medicine Associates (RMA) of New York, visit www.rmany.com for complete information. You can also visit Dr. Copperman’...